Stock Events

Stock Events

Genocea Biosciences 

0
0
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

1JanExpected
Q4 0
-0.15
0.18
0.51
0.85
Expected EPS
-0.15176
Actual EPS
N/A

Financials

-2,021.18%Profit Margin
Unprofitable
2016
2017
2018
2019
2020
2021
1.42MRevenue
-28.66MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow GBI.MU. It's not an investment recommendation.
Amazon
2
AMZN
NVIDIA
2
NVDA
Uber Technologies
2
UBER
SNDL
2
SNDL

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
BioNTech
BNTX
Mkt Cap25.64B
BioNTech SE works on individualized cancer medicine and mRNA-based vaccines, competing in the personalized immunotherapy space.
Moderna
MRNA
Mkt Cap55.09B
Moderna, Inc. is known for its mRNA technology platform, which is used for vaccine development, including cancer vaccines.
Novavax
NVAX
Mkt Cap1.53B
Novavax, Inc. is involved in the development of vaccines for infectious diseases, competing indirectly in the vaccine development space.
Gilead Sciences
GILD
Mkt Cap180.64B
Gilead Sciences, Inc. has a strong presence in the development of treatments for infectious diseases, including HIV and hepatitis B and C, areas where Genocea has shown interest.
Incyte
INCY
Mkt Cap25.21B
Incyte Corporation focuses on the discovery, development, and commercialization of proprietary therapeutics, including cancer treatments, making it a competitor.
AMGEN
AMGN
Mkt Cap233.78B
Amgen Inc. is a biotechnology giant that develops innovative human therapeutics, including in the oncology and inflammation areas.
Pfizer
PFE
Mkt Cap159.36B
Pfizer Inc. has a broad portfolio including vaccines and cancer treatments, making it a competitor in multiple areas of Genocea's interest.
Merck
MRK
Mkt Cap366B
Merck & Co., Inc. is a leading pharmaceutical company with a strong focus on cancer treatments and vaccines, directly competing with Genocea's cancer vaccine development.
Bristol-Myers Squibb
BMY
Mkt Cap136B
Bristol-Myers Squibb Company is involved in the discovery, development, and delivery of medicines, including cancer immunotherapies, competing in the oncology space.

About

GENOCEA BIOSCIENCES INC
Show more...
CEO
Country
United States
ISIN
US3724271040

Listings

MU
DE
GBI.MU
STU
DE
GBI.STU
OTC Link
US
GNCAQ
LSE
GB
0A51.LSE

0 Comments

Share your thoughts

FAQ

What is Genocea Biosciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange Genocea Biosciences stocks are traded under the ticker GBI.MU.
What is Genocea Biosciences revenue for the last year?▼
Genocea Biosciences revenue for the last year amounts to 1.42M EUR.
What is Genocea Biosciences net income for the last year?▼
GBI.MU net income for the last year is -28.66M EUR.
In which sector is Genocea Biosciences located?▼
Genocea Biosciences operates in the Other sector.
When did Genocea Biosciences complete a stock split?▼
The last stock split for Genocea Biosciences was on May 22, 2019 with a ratio of 1:8.